Literature DB >> 6734694

Effect of oxprenolol and metoprolol on serum lipid concentration.

L A Ferrara, T Marotta, A Scilla, P Mastranzo, P Strazzullo, M Mancini.   

Abstract

The aim of the present study was to evaluate whether a reduction in HDL-cholesterol is peculiar to non cardioselective beta blockers or whether it is also produced by cardioselective beta 1-blockers. 16 patients with primary arterial hypertension on a balanced isocaloric diet were given oxprenolol 120 to 240 mg/day or metoprolol 100 to 200 mg/day in a random cross-over study. No significant change was observed after either treatment in fasting blood glucose, serum total cholesterol and triglycerides. HDL-cholesterol concentration was significantly decreased on metoprolol, from 41 to 36 mg/dl (p less than 0.05), while oxprenolol did not affect it at all. The difference might depend on intrinsic sympathomimetic activity which is possessed by oxprenolol and which metoprolol lacks.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6734694     DOI: 10.1007/BF00548763

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  27 in total

Review 1.  Drug therapy: metoprolol.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

2.  Dyslipoproteinemia in patients with ischemic cerebro-vascular disease: a study of stroke before the age of 55.

Authors:  S Rössner; K G Kjellin; K L Mettinger; A Sidén; C E Söderström
Journal:  Atherosclerosis       Date:  1978-07       Impact factor: 5.162

3.  High density lipoproteins reduce the uptake of low density lipoproteins by human endothelial cells in culture.

Authors:  O Stein; Y Stein
Journal:  Biochim Biophys Acta       Date:  1976-05-27

Review 4.  The metabolic role of lecithin: cholesterol acyltransferase: perspectives form pathology.

Authors:  J A Glomset; K R Norum
Journal:  Adv Lipid Res       Date:  1973

5.  The effect of metoprolol on plasma lipids.

Authors:  I W Beinart; D G Cramp; R M Pearson; C W Havard
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

6.  Decreased high density lipoprotein-cholesterol levels in male patients with transient ischemic attacks.

Authors:  C R Sirtori; G Gianfranceschi; I Gritti; G Nappi; G Brambilla; P Paoletti
Journal:  Atherosclerosis       Date:  1979-02       Impact factor: 5.162

7.  Glucose tolerance and blood pressure in two population samples: their relation to diabetes mellitus and hypertension.

Authors:  R J Jarrett; H Keen; M McCartney; J H Fuller; P J Hamilton; D D Reid; G Rose
Journal:  Int J Epidemiol       Date:  1978-03       Impact factor: 7.196

8.  Inhibition of human fat cell adenylate cyclase mediated via alpha-adrenoceptors.

Authors:  H Kather; J Pries; V Schrader; B Simon
Journal:  Eur J Clin Invest       Date:  1980-10       Impact factor: 4.686

9.  Effect of pindolol on serum lipids and lipid metabolizing enzymes.

Authors:  A Lehtonen; E Hietanen; J Marniemi; P Peltonen; J Niskanen
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

10.  Effect of propranolol and prazosin on blood lipids. The Oslo Study.

Authors:  P Leren; P O Foss; A Helgeland; I Hjermann; I Holme; P G Lund-Larsen
Journal:  Lancet       Date:  1980-07-05       Impact factor: 79.321

View more
  2 in total

1.  Adrenergic blocking agents and lipoprotein lipase activity.

Authors:  P Rubba; B De Simone; T Marotta; G Leccia; S Soro; L A Ferrara
Journal:  J Endocrinol Invest       Date:  1989-02       Impact factor: 4.256

2.  Effect of lacidipine, a long-acting calcium antagonist, on hypertension and lipids: a 1 year follow-up.

Authors:  S Soro; L A Ferrara
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.